All Stories

  1. Prediction of ventilator-associated pneumonia outcomes according to the early microbiological response: a retrospective observational study
  2. Optimal approaches to preventing severe community-acquired pneumonia
  3. Perspectives on synthetic pharmacotherapy for the treatment of nosocomial pneumonia
  4. Drugs that increase the risk of community-acquired pneumonia: a narrative review
  5. Community-acquired bacterial pneumonia in adult HIV-infected patients
  6. Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
  7. New Sepsis Definition (Sepsis-3) and Community-acquired Pneumonia Mortality. A Validation and Clinical Decision-Making Study
  8. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
  9. Biofilms in ventilator-associated pneumonia
  10. Laboratory diagnosis of pneumonia in the molecular age
  11. Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia
  12. Multilobar bilateral and unilateral chest radiograph involvement: implications for prognosis in hospitalised community-acquired pneumonia
  13. Bacteraemia in outpatients with community-acquired pneumonia
  14. Ceftobiprole for the treatment of pneumonia: a European perspective
  15. Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis
  16. Community-acquired pneumonia: Changing paradigms about mortality